Seniors Miss Out on Services With Medicare Advantage
By Dennis Thompson HealthDay Reporter
TUESDAY, Jan. 21, 2025 -- Medicare Advantage isn’t that great an advantage for seniors compared with traditional Medicare, researchers say.
The privatized form of Medicare offers more supplemental benefits than traditional Medicare, including dental, vision and hearing benefits.
But many seniors aren’t using those additional benefits, and their out-of-pocket costs are about the same as with regular Medicare, researchers report in a study published recently in JAMA Network Open.
For example, just a little more than half of seniors (54%) with Medicare Advantage are aware of having either dental or vision coverage, even though nearly all plans offer those benefits, results show.
“Supplemental benefits are a major draw to Medicare Advantage, but our findings show that people enrolled in Medicare Advantage have no better access to extra services than people in traditional Medicare, and that much of the cost comes out of their own pockets,” senior researcher Dr. Lisa Simon, an assistant professor of general and internal medicine at Brigham and Women’s Hospital in Boston, said in a news release.
“Older adults and people with disabilities deserve better from Medicare,” Simon added.
About 51% of Medicare beneficiaries enrolled in Medicare Advantage in 2023, researchers said in background notes.
The federal government pays Medicare Advantage plans about 22% more than the cost of covering similar beneficiaries under traditional Medicare, which amounted to about $83 billion in 2024.
For the study, researchers analyzed data from 2017 to 2021 gathered by an annual Centers for Medicare and Medicaid Services beneficiary survey, as well as an annual federal review of the cost of health care in the U.S.
Seniors pay about the same or slightly less out-of-pocket for services under Medicare Advantage compared to traditional Medicare, researchers found.
For example, Medicare Advantage beneficiaries paid nearly $206 for eyeglasses, about 9% less than the $226 paid under traditional Medicare.
Similarly, seniors paid nearly $227 for dental visits under Medicare Advantage, about 9% less than the $250 paid by people in traditional Medicare.
Seniors in either plan paid about the same for optometry visits and durable medical equipment like hearing aids, results show.
Nationwide, Medicare Advantage plans spent about $3.9 billion on vision, dental services and durable medical equipment, while enrollees spent $9.2 billion out-of-pocket for those services and supplemental insurance covered $2.8 billion.
Overall, private Medicare Advantage plans received $37.2 billion more a year in federal funding than taxpayers would have spent if the beneficiaries had enrolled in traditional Medicare, researchers concluded.
“Medicare Advantage plans receive more money per beneficiary than traditional Medicare plans, but our findings add to the evidence that this increased cost is not justified,” lead researcher Dr. Christopher Cai, a resident with Brigham and Women’s Hospital, said in a news release.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-22 06:00
Read more
- Cancer Deaths Dropping Despite Rise in New Cases
- Some Brain Cells Change with Age, Some Don't: Study
- Black Patients Less Likely To Get Weight Loss Surgery
- AI Can Reliably Predict Efficacy of Immune Checkpoint Inhibitor Therapy
- Tourette Syndrome Often Overlooked in Girls
- Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions